CGI Biomarkers database¶
Description¶
This database is used by Cancer Genome Interpreter (CGI) as a source to assess the relevance of the alterations as biomarkers of drug response.
The biomarkers are classified by cancer type, drug response (sensitivity/resistance/toxicity) and the level of clinical evidence supporting this association.
The database was created by several clinical and scientific experts in the field of precision oncology and it is currently curated and maintained by the CGI expertise team, through reviewing the guidelines (FDA-Approvals and NCCN Guidelines) on drug approvals.
The CGI Biomarkers database was last updated in October 2022.
Data access¶
Click to access the dataset:
Citing in Publications and Presentations¶
When referring to the datasets any result generated by the CGI framework or the CGI resource itself, please cite:
Tamborero, D., Rubio-Perez, C., Deu-Pons, J. et al. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med 10, 25 (2018). https://doi.org/10.1186/s13073-018-0531-8
More information¶
If you want more information check: https://www.cancergenomeinterpreter.org/faq#q12
Reference¶
- Magda Guardiola Fernández